Full name
NANO CARE PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
NANO CARE PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. RYMANOWSKA 2, 02-916 WARSZAWA
TAX ID5272697822
Rate company:
NANO CARE PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5272697822
KRS0000471964
Share capital5,100.00 zł
address
UL. RYMANOWSKA 2, 02-916 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5272697822
REGON
146788638
KRS
0000471964
Legal form
limited liability company
Register Address
UL. RYMANOWSKA 2, 02-916 WARSZAWA
Date of registration in KRS
2013-07-31
Date of commencement of economic activity
2013-07-31
Act signature
WA.XIII NS-REJ.KRS/49672/24/336
Pkd codes
10.89.Z - Manufacture of other food products not elsewhere classified
20.42.Z - Manufacture of perfumes and toilet preparations
47.29.Z - Other retail sale of food in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
72.11.Z - Research and experimental development on biotechnology
73 - Advertising and market research
85 - Education
86.90.E - Other human health activities notelsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL39 1090 2590 0000 0001 3379 1880 
PL23 2490 0005 0000 4520 6600 3643 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2019 | 2020 | 2021 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets  | 249,8 | 253,5 | 269,6 | 6,4 |
Gross profit (loss) | -0,8 | 10,4 | 23,2 | 122,8 |
EBITDA | 35 | 26,8 | 39,9 | 48,9 |
Net profit (loss) | -0,8 | 9,7 | 21,2 | 118,9 |
Cash | 8,7 | 11,6 | 65,4 | 465,2 |
Liabilities and provisions for liabilities | 212,1 | 206,1 | 201 | -2,5 |
Net income from sale | 345,8 | 159,8 | 145,4 | -9 |
Short time liabilities | 0,1 | 2,3 | 32,7 | 1308,1 |
Equity capital | 37,7 | 47,4 | 68,6 | 44,8 |
Working assets | 249,8 | 227,8 | 269,6 | 18,4 |
Operating profit (EBIT) | 15,9 | 26,8 | 31,3 | 16,9 |
Depreciation | 19,1 | 0 | 8,6 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -2,2 | 20,5 | 30,9 | 10,4 |
Equity capital to total assets | 15,1 | 18,7 | 25,5 | 6,8 |
Gross profit margin | -0,2 | 6,5 | 15,9 | 9,4 |
EBITDA Margin | 10,1 | 16,8 | 27,4 | 10,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 5 | 82 | 77 |
Financial statements
01-01-2021 - 31-12-2021
Annual financial report
Download xml01-01-2021 - 31-12-2021
Annual financial report
Download pdf01-01-2021 - 31-12-2021
Resolution on profit distribution or loss coverage
Download pdf01-01-2021 - 31-12-2021
Resolution or decision approving the annual financial statements
Download pdf01-01-2021 - 31-12-2021
Activity report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Mariusz Okliński
Gdańsk
Bart-ol Sp. z o.o.
Aleksandrów Łódzki
Gminna Spółdzielnia Socjalna Przyszłość
Soborzyce
MARIA PERŁOWSKA PERŁOWSCY
Kraków
URBAN4TRADE Leszek Urban
Nowa Sól
Novopharma sp. z o.o.
Wrocław